Manzo Pharmaceuticals (MNZO)
OTHER OTC:MNZO
US Market
Holding MNZO?
Track your performance easily

Manzo Pharmaceuticals (MNZO) Financial Statements

0 Followers

Manzo Pharmaceuticals Financial Overview

Manzo Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Manzo Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 05Dec 04Sep 04
Income Statement-
Total Revenue$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 37.17K$ -64.94K
EBIT$ 0.00$ -2.84M$ -94.78K
EBITDA$ 27.89K$ -2.84M$ -64.94K
Net Income Common Stockholders$ -1.23M$ -1.04M$ -1.02M
Balance Sheet-
Cash Cash Equivalents And Short Term Investments$ 6.91K$ 9.78K-
Total Assets$ 4.05M$ 1.29M-
Total Debt$ 5.12M$ 6.52M$ 0.00
Net Debt$ 5.11M$ 6.51M$ 0.00
Total Liabilities$ 15.79M$ 23.79M-
Stockholders Equity$ -11.74M$ -22.50M-
Cash Flow-
Free Cash Flow-$ -608.34K-
Operating Cash Flow-$ -608.34K-
Investing Cash Flow-$ -1.00-
Financing Cash Flow-$ 627.08K-
Currency in USD

Manzo Pharmaceuticals Earnings and Revenue History

Manzo Pharmaceuticals Debt to Assets

Manzo Pharmaceuticals Cash Flow

Manzo Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis